Evolent Health, Inc.: management transactions · United States · SEC (Form 4)

About Evolent Health, Inc.

Evolent Health, Inc. (NYSE: EVH) is a United States-listed healthcare company headquartered in Arlington, Virginia. Founded in the early 2010s by healthcare executives including Seth Blackley, the company built its platform around improving clinical outcomes and lowering the cost and administrative complexity of care for patients with complex conditions. From its origins as a value-based care platform, Evolent has evolved through a mix of organic growth and acquisitions into a more focused specialty care management business serving national payers and provider organizations across the United States. ([evolent.com](https://www.evolent.com/about-us)) Evolent’s core positioning is in specialty condition management and health care simplification. Its solution set spans performance-oriented care management, specialty technology and services, and administrative services. In practice, that means the company helps health plans and providers manage high-cost, high-variability areas such as oncology, cardiology, musculoskeletal care, surgical management and advanced imaging. Its model combines clinical expertise, data-driven workflows, automation and payer-provider collaboration to improve outcomes while reducing avoidable utilization and administrative burden. ([evolent.com](https://www.evolent.com/about-us)) From a competitive standpoint, Evolent is not trying to be a broad diversified health insurer or a generic services vendor. Instead, it competes as a specialist with deep clinical capabilities and a focused product stack aimed at complex conditions. That specialization is important in a market where rising medical costs and pressure to improve quality are pushing payers to seek external expertise. Management has repeatedly highlighted a strong selling environment, low market penetration in its addressable categories, and the ability to expand existing relationships by geography, line of business or service scope. ([ir.evolent.com](https://ir.evolent.com/2025-05-08-Evolent-Announces-First-Quarter-2025-Results)) The company’s growth history has been shaped by acquisitions designed to broaden its specialty footprint. Notable transactions include New Century Health, IPG and Vital Decisions, which expanded Evolent’s capabilities in specialty care, surgical management and advance care planning. More recently, Evolent announced the divestiture of Evolent Care Partners, its value-based primary care business, to sharpen its focus on specialty condition management and accelerate deleveraging. That move signals a more disciplined portfolio strategy and a clearer emphasis on cash generation and balance-sheet improvement. ([ir.evolent.com](https://ir.evolent.com/2018-10-02-Evolent-Health-Completes-Acquisition-of-New-Century-Health?utm_source=openai)) Geographically, Evolent operates primarily in the United States and serves a national client base rather than being concentrated in a single region. Recent disclosures show deployments across multiple lines of business, including Medicare Advantage, Medicaid and commercial plans, with new wins and expansions in several U.S. markets. At the start of 2025, the company reported five new revenue agreements and reiterated full-year guidance, while also emphasizing its growing pipeline, AI-enabled automation initiatives and continued focus on profitability and debt paydown. For investors, EVH is a U.S. healthcare services name with a specialized growth profile, meaningful execution leverage and exposure to both demand tailwinds and reimbursement/regulatory complexity. ([ir.evolent.com](https://ir.evolent.com/2025-05-08-Evolent-Announces-First-Quarter-2025-Results))